| scholarly article | Q13442814 |
| P50 | author | Dianne M Hezel | Q89720558 |
| P2093 | author name string | H Blair Simpson | |
| P2860 | cites work | Prevalence, Severity, and Unmet Need for Treatment of Mental Disorders in the World Health Organization World Mental Health Surveys | Q22252996 |
| Randomized, Placebo-Controlled Trial of Exposure and Ritual Prevention, Clomipramine, and Their Combination in the Treatment of Obsessive-Compulsive Disorder | Q22306279 | ||
| Virtual reality exposure therapy for active duty soldiers | Q28286568 | ||
| Modular Cognitive Therapy for Obsessive-Compulsive Disorder: A Wait-List Controlled Trial | Q30434195 | ||
| Deep brain stimulation of the ventral striatum enhances extinction of conditioned fear | Q30514335 | ||
| FAAH genetic variation enhances fronto-amygdala function in mouse and human | Q30625337 | ||
| Internet-based cognitive behavior therapy for obsessive compulsive disorder: a pilot study | Q31029177 | ||
| How psychotherapy changes the brain--the contribution of functional neuroimaging | Q33235643 | ||
| The effect of attention training on a behavioral test of contamination fears in individuals with subclinical obsessive-compulsive symptoms | Q33836858 | ||
| Rapid effects of brief intensive cognitive-behavioral therapy on brain glucose metabolism in obsessive-compulsive disorder | Q33946894 | ||
| Maximizing exposure therapy: an inhibitory learning approach | Q33968137 | ||
| A multidimensional meta-analysis of psychotherapy and pharmacotherapy for obsessive-compulsive disorder | Q33982952 | ||
| The psychological treatment of obsessive-compulsive disorder | Q33997594 | ||
| Goal-directed learning and obsessive-compulsive disorder | Q34291912 | ||
| Repetitive transcranial magnetic stimulation (rTMS) for obsessive-compulsive disorder (OCD): an exploratory meta-analysis of randomized and sham-controlled trials | Q34341099 | ||
| Differential prefrontal gray matter correlates of treatment response to fluoxetine or cognitive-behavioral therapy in obsessive-compulsive disorder | Q48426191 | ||
| Barriers to treatment and service utilization in an internet sample of individuals with obsessive-compulsive symptoms | Q48818905 | ||
| Controlled trial of exposure and response prevention in obsessive-compulsive disorder. | Q51101421 | ||
| Cognitive-behavioral treatment of obsessive thoughts: a controlled study. | Q52001219 | ||
| Changes in quality of life following cognitive-behavioral therapy for obsessive-compulsive disorder. | Q53188832 | ||
| Obsessional-compulsive problems: a cognitive-behavioural analysis. | Q53772537 | ||
| Transcranial Direct Current Stimulation for Obsessive-Compulsive Disorder: A Systematic Review. | Q55007757 | ||
| Treatment of obsessive-compulsive disorder by U.S. psychiatrists. | Q55042213 | ||
| Long-term efficacy of Internet-based cognitive behavior therapy for obsessive–compulsive disorder with or without booster: a randomized controlled trial | Q57396003 | ||
| Response versus remission in obsessive-compulsive disorder | Q57829344 | ||
| Brain Derived Neurotrophic Factor (BDNF) gene variants association with age at onset and therapeutic response in schizophrenia | Q59668718 | ||
| Effectiveness of exposure and ritual prevention for obsessive-compulsive disorder: Randomized compared with nonrandomized samples | Q60204835 | ||
| Cognitive assessment of obsessive-compulsive disorder | Q60456915 | ||
| Virtual reality exposure therapy for anxiety disorders: A meta-analysis | Q60630250 | ||
| A cognitive theory of obsessions | Q61772201 | ||
| Modification of expectations in cases with obsessional rituals | Q72940795 | ||
| Acceptability, Feasibility, and Effectiveness of Internet-Based Cognitive-Behavioral Therapy for Obsessive-Compulsive Disorder in New York | Q89222798 | ||
| Effectiveness of psychological and pharmacological treatments for obsessive-compulsive disorder: a quantitative review | Q34421698 | ||
| Acceptance and commitment therapy for anxiety and OCD spectrum disorders: an empirical review | Q34429854 | ||
| Augmentation of behavior therapy with D-cycloserine for obsessive-compulsive disorder | Q34744905 | ||
| Context in the clinic: how well do cognitive-behavioral therapies and medications work in combination? | Q35001306 | ||
| Mechanisms of change in cognitive therapy for obsessive compulsive disorder: role of maladaptive beliefs and schemas | Q35036969 | ||
| Six-month outcomes from a randomized trial augmenting serotonin reuptake inhibitors with exposure and response prevention or risperidone in adults with obsessive-compulsive disorder | Q35914688 | ||
| Neurotrophic gene polymorphisms and response to psychological therapy. | Q36001550 | ||
| Common Pitfalls in Exposure and Response Prevention (EX/RP) for OCD | Q36178558 | ||
| Internet-based cognitive behaviour therapy for obsessive-compulsive disorder: a randomized controlled trial | Q36214868 | ||
| Response to psychotherapy in borderline personality disorder and methylation status of the BDNF gene | Q36593830 | ||
| Sleep-related problems in pediatric obsessive-compulsive disorder | Q36700775 | ||
| Optimizing inhibitory learning during exposure therapy | Q37001976 | ||
| Does cognitive behavioral therapy change the brain? A systematic review of neuroimaging in anxiety disorders | Q37557981 | ||
| Psychotherapy for obsessive-compulsive disorder | Q37563543 | ||
| A randomized, controlled trial of cognitive-behavioral therapy for augmenting pharmacotherapy in obsessive-compulsive disorder | Q37623353 | ||
| Patient adherence to cognitive-behavioral therapy predicts long-term outcome in obsessive-compulsive disorder | Q37632612 | ||
| Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: a randomized clinical trial | Q37639264 | ||
| Genetic variation in the endocannabinoid system and response to Cognitive Behavior Therapy for child anxiety disorders | Q37663920 | ||
| Efficacy of cognitive behavioral therapy for anxiety disorders: a review of meta-analytic findings | Q37769707 | ||
| Safety and efficacy of repetitive transcranial magnetic stimulation in the treatment of obsessive-compulsive disorder: a review. | Q37881952 | ||
| Cognitive-behavioral therapy for obsessive-compulsive disorder: a meta-analysis of treatment outcome and moderators. | Q38045577 | ||
| Commonly asked questions in the treatment of obsessive-compulsive disorder | Q38174158 | ||
| The global burden of anxiety disorders in 2010. | Q38180929 | ||
| Obsessive-compulsive disorder: an integrative genetic and neurobiological perspective | Q38212792 | ||
| Behavioral versus cognitive treatment of obsessive-compulsive disorder: an examination of outcome and mediators of change | Q38398101 | ||
| Transcranial direct current stimulation in obsessive-compulsive disorder: emerging clinical evidence and considerations for optimal montage of electrodes. | Q38486000 | ||
| The Efficacy of Exposure Therapy for Anxiety-Related Disorders and Its Underlying Mechanisms: The Case of OCD and PTSD. | Q38632526 | ||
| A Theoretical review of cognitive biases and deficits in obsessive-compulsive disorder | Q38643171 | ||
| Treatment of chronic obsessive-compulsive neurosis by in-vivo exposure. A two-year follow-up and issues in treatment | Q40346732 | ||
| Three-year outcomes in deep brain stimulation for highly resistant obsessive-compulsive disorder | Q42692078 | ||
| Need for speed: evaluating slopes of OCD recovery in behavior therapy enhanced with d-cycloserine | Q43110632 | ||
| Brain regions related to fear extinction in obsessive-compulsive disorder and its relation to exposure therapy outcome: a morphometric study. | Q44915560 | ||
| Mechanisms of symptom reduction in treatment for obsessions | Q45414297 | ||
| A comparison of behavioral group therapy and individual behavior therapy in treating obsessive-compulsive disorder | Q46339879 | ||
| Anxiety provocation and measurement using virtual reality in patients with obsessive-compulsive disorder | Q47246983 | ||
| Cognitive-behavioural therapy augments the effects of deep brain stimulation in obsessive-compulsive disorder | Q48246417 | ||
| Transcranial direct current stimulation and cognitive-behavioral therapy: evidence of a synergistic effect in treatment-resistant depression | Q48352474 | ||
| P433 | issue | Suppl 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | obsessive-compulsive disorder | Q178190 |
| P304 | page(s) | S85-S92 | |
| P577 | publication date | 2019-01-01 | |
| P1433 | published in | Indian Journal of Psychiatry | Q6020816 |
| P1476 | title | Exposure and response prevention for obsessive-compulsive disorder: A review and new directions | |
| P478 | volume | 61 |
| Q89755250 | Cannabinoid Augmentation of Exposure-Based Psychotherapy for Obsessive-Compulsive Disorder |
| Q89702242 | Clinical Practice Guidelines for Cognitive-Behavioral Therapies in Anxiety Disorders and Obsessive-Compulsive and Related Disorders |
| Q90097409 | Trichotillomania comorbidity in a sample enriched for familial obsessive-compulsive disorder |
Search more.